MMG

MMG names Chris Middleton vice president of technology

Friday, February 10, 2012 11:47 AM

MMG, a global clinical trials patient recruitment group, part of Ketchum, has appointed Chris Middleton vice president of technology.

More... »


MMG CEO John Benbrook named to CISCRP board of advisors

Friday, March 18, 2011 10:47 AM

The Center for Information and Study on Clinical Research Participation (CISCRP) has named John Benbrook, CEO of MMG, a patient recruitment and retention company, to its board of advisors.

More... »


MMG Partners With Exco InTouch

Thursday, September 18, 2008 04:45 PM

Global patient recruitment and retention firm MMG has partnered with Exco InTouch to provide mobile messaging services to its sponsor clients. According to the Rockville, Md.-based company, Exco’s mobile technology will enable sponsors to quickly identify and pre-screen potential subjects for clinical studies, as well as provide ongoing contact with patients via mobile messages, reducing the amount of input required from study organizers.

More... »


CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks worldwide toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs